Biopharmaceutical Analysis

Feliza Mirasol is the science editor for 

Videos

At INTERPHEX 2024, Jay Rajagopalan, senior director—Engineering & Product Management for Malema at PSG Biotech, discussed how the advancement of sensor technologies are being shaped by current industry trends.

Discussing Impact on Sensor Technologies from Industry Trends (INTERPHEX 2024)

Articles

Roche will acquire select parts of the LumiraDx group related to that company’s point-of-care technology, which integrates multiple tests on a single instrument. 

Roche to Acquire Point-of-Care Technology from LumiraDx in $350 Million Deal

Karin Kottig, PhD, is head of Contract Service Analytics, Vetter Development Service.

Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.

Stability Studies: An Essential Step for Quality Management in Drug Development

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights the company’s motivation behind their new bioanalysis kit for oligonucleotides.

The Need for New Bioanalysis Technology (AAPS PharmSci 360)

Waters has launched OligoWorks SPE Workflow and Kits, which is aimed at accelerating the bioanalysis of oligonucleotides.

Waters Launches New Oligonucleotide Bioanalysis Kits

SCHOTT now offers ViewCell, a new component meant to add flexibility to biopharmaceutical process control.

SCHOTT Launches ViewCell Flow Cell for Biopharma Process Control

Grant Playter is the Assistant Editor for 

Sandbox AQ’s molecular simulation division is collaborating with companies like AstraZeneca and Sanofi to develop novel treatments for various disorders.

SandboxAQ Launches Molecular Simulation Division

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.

Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis

Marwan Alsarraj is the Biopharma Segment manager at Bio-Rad.

One get obtain a clearer assessment of gene-editing outcomes through more exacting analytical tools.



Using ddPCR to Assess the Success of CRISPR Gene Therapies

PerkinElmer has expanded its genomics testing services with the launch of its ultrarapid whole genome sequencing.

Analytical Instrumentation